Cancer screening: An educational challenge?

European Journal of Cancer Prevention

Volumn 8, Issue 1, 1999, Pages 7-16

  Moore, M A ^a   Tsuda, H ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Co ordinated approach; Early detection; Education; Screening

Indexed keywords

CANCER SCREENING; EARLY CANCER; EARLY DIAGNOSIS; EDUCATION PROGRAM; HEALTH CARE UTILIZATION; HEALTH PROMOTION; HUMAN; PRIORITY JOURNAL; REVIEW;

EDUCATION, MEDICAL; HEALTH EDUCATION; HUMANS; MASS SCREENING; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SELF-EXAMINATION; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 0032980097     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: None     Document Type: Article

References (113)

1. Achkar E, Carey W (1989). The cost of surveillance for adenocarcinoma complicating Barrett’s esophagus. Am J Gastroenterol 83: 291-4.
2. Adonakis GL, Paraskevaidis E, Tsiga S et al. (1996). A combined approach for the early detection of ovarian cancer in asymptomatic women. Eur J Obstetrics Gynecol Reprod Biol 65: 221-5.
3. Albertsen PC (1996). Screening for prostate cancer is neither appropriate nor cost-effective. Urol Clin N Am 23: 521-30.
4. Babazono A, Hillman AL (1995). Declining cost-effectiveness of screening for disease. The case of gastric cancer in Japan. Int J Technology Assess Health Care 11: 354-64.
5. Baines CJ (1995). The Canadian National Breast Screening Study. Why? What next? And so what? Cancer 76: 2107-12.
6. Baumgartner R, Huber RM, Schulz H et al. (1996). Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J Photochem Photobiol B Biol 36: 169-74.
7. Bintinx F, Wauters H (1997). The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a metanalysis. Fam Pract 14: 63-8.
8. Brentnall TA, Haggitt RC, Rabinovitch PS et al. (1996). Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110: 331-8.
9. Breslow RA, Sorkin JD, Frey CM, Kessler LG (1997). Americans' knowledge of cancer risk and survival. Prev Med 26: 170-7.
10. Burzynski NJ, Firriolo FJ, Butters JM, Sorrell CL (1997). Evaluation of oral cancer screening. J Cancer Ed 12: 95-9.
11. Calabrese L, Tradati N, Nickolas TL et al. (1998). Cancer screening in otorhinolaryngology. Oral Oncol 34: 1-4.
12. Carpenter V, Colwell B (1995). Cancer knowledge, self-efficacy, and cancer screening behaviors among Mexican-American women. J Cancer Ed 10: 217-22.
13. Chamberlain RM, Smith DW, Zhang JJ et al. (1995). Improving residents’ knowledge of cancer prevention: are physicians prepared for prevention? J Cancer Ed 10: 9-13.
14. Chapman GB, Elstein AS (1995). Valuing the future: temporal discounting of health and money. Med Decision Making 15: 373-86.
15. Ciatto S, Cecchini S, Bonardi R et al. (1995). A feasibility study of screening for endometrial carcinoma in postmenopausal women by ultrasonography. Tumori 81: 334-7.
16. Cooper DS, Axelrod L, DeGroot LJ (1981). Congenital goiter and the development of metastatic follicular carcinoma with evidence for a leak of non-hormonal iodide: clinical, pathological, kinetic and biochemical studies and a review of the literature. J Clin Endocrinol Metab 52: 294-306.
17. Crom DB, Kaste SC, Tubergen DG et al. (1997). Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors. Med Pediatric Oncol 28: 15-21.
18. Curley SA, Izzo F, Gallipoli A et al. (1995). Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg 222: 375-83.
19. Dorum A, Kristensen GB, Abeler VM et al. (1996). Early detection of familial ovarian cancer. EurJ Cancer 32: 1645-51.
20. Duffy SW, Chen FIH, Tabar L et al. (1996). Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49. Int J Epidemiol 25: 1139-45.
21. Friedman GD, Carroll PR, Cattolica EV, Hiatt RA (1996). Can hematuria be a predictor as well as a symptom or sign of bladder cancer? Cancer Epidemiol Biomarkers Prev 5: 993-6.
22. Friedman GD, Hiatt RA, Quesenberry CP Jr, Selby JV (1991). Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet 337: 1526-9.
23. Gabriel H, Wilson TE, Helvie MA (1997). Breast cancer in women 64-74 years old: earlier detection by mammographic screening. Am J Roentgenol 168: 23-7.
24. Gann PH, Hennekens CH, Stampfer MJ (1995). A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 273: 289-94.
25. Geul KW, Bosman FT, van Blankenstein M et al. (1997). Prevention of colorectal cancer. Costs and effectiveness of sigmoidoscopy. Scand J Gastroenterol 223 (Suppl): 79-87.
26. Girgis A, Clarke P, Burton RC, Sanson-Fisher RW (1996). Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen 3: 47-53.
27. Girgis A, Sanson-Fisher RW (1996). Skin cancer prevention, early detection and management: current beliefs and practices of Australian family physicians. Cancer Detect Prev 20: 316-24.
28. Grol R (1997). Beliefs and evidence in changing clinical practice. BMJ 315: 418-21.
29. Gronroos M, Salmi TA, Vuento MH et al. (1993). Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension. Cancer 71: 1279-82.
30. Gull B, Karlsson B, Milsom I et al. (1996). Transvaginal sonography of the endometrium in a representative sample of postmenopausal women. Ultrasound Obstet Gynecol 1: 322-7.
31. Haggitt RC (1994). Barrett’s esophagus, dysplasia and adenocarcinoma. Human Pathol 25: 982-93.
32. Hardcastle JD, Chamberlain JO, Robinson MH et al. (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472-7.
33. Hart AR, Barone TL, Gay SP et al. (1997). The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England. J Epidemiol Comm Hlth 51: 187-91.
34. Hassall E, Dimmick JE, Agee JF (1993). Adenocarcinoma in childhood Barrett’s esophagus: case documentation and the need for surveillance in children. Am J Gastroenterol 88: 222-8.
35. Haynes SG, Odenkirchen J, Heimendinger J (1990). Worksite health promotion for cancer control. Seminars Oncol 17: 463-84.
36. Helzlsouer KL, Alberg AJ, Gordon GB et al. (1995). Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 274: 1926-30.
37. Helzlsouer KJ, Ford DE, Hayward RS et al. (1994). Perceived risk of cancer and practice of cancer prevention behaviors among employees in an oncology center. Prev Med 23: 302-8.
38. Hiatt RA, Ordonez JD (1994). Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. Cancer Epidemiol Biomarkers Prev 3: 439-443.
39. Hristova L, Hakama M (1997). Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Acta Oncol 36 (Suppl 9): 1-60.
40. Ikeda N, Downer MC, Ishii T et al. (1995). Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Comm Dental Hlth 12: 133-7.
41. Jullien JA, Downer MC, Speight PM, Zakrzewska JM (1996). Evaluation of health care workers’ accuracy in recognising oral cancer and pre-cancer. Int Dent J 46: 334-9.
42. Karlan BY, Platt LD (1995). Ovarian cancer screening. The role of ultrasound in early detection. Cancer 76: 2011-15.
43. Kennedy TC, Proudfoot SP, Franklin WA et al. (1996). Cytiopathological analysis of sputum inpatients with airflow obstruction and significant smoking histories. Cancer Res 56: 4673-8.
44. Kryger JV, Messing E (1996). Bladder cancer screening. Seminars Oncol 23: 58-97.
45. Kwasniewski A, Tukendorf A, Semzuk M (1997). Content of o-tocopherol in blood serum of human papillomavirus-infected women with cervical dysplasias. Nutr Cancer 28: 248-51.
46. Law J (1997). Cancers detected and induced in mammographic screening: new screening schedules and younger women with family history. Br J Radiol 70: 62-9.
47. Lerman C, Rimer B, Glynn T (1997). Priorities in behavioural research in cancer prevention and control. Prev Med 26: S3-S9.
48. Lerut T, Coosemans W, Van Raemdonck D et al. (1994). Surgical treatment of Barrett’s carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg 107: 1059-65; discussion 1065-6.
49. Liu SF, Shen Q, Dawsey SM et al. (1994). Esophageal balloon cytology and subsequent risk of esophageal and gastric-cardia cancer in a high-risk Chinese population. Int J Cancer 57: 77-80.
50. Lodi G, Bez C, Rimondini L et al. (1997). Attitude towards smoking and oral cancer prevention among northern Italian dentists. Oral Oncol 33: 100-4.
51. Lynch HT, Fusaro RM, Lynch J (1995). Hereditary cancer in adults. Cancer Epidemiol Detect Prev 19: 219-33.
52. Makino H, Sato S, Yajima A et al. (1995). Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan. Tohoku J Exp Med 175: 171-8.
53. Mandel JS (1997). Colorectal cancer screening. Cancer Metastasis Rev 16: 263-79.
54. Mandelblatt J, Freeman H, Winczewski D et al. (1997). The costs and effects of cervical and breast cancer screening in a public hospital emergency room. The Cancer Control Center of Harlem. Am J Publ Hlth 87: 1182-9.
55. Manus B, Bragelmann R, Armbrecht U et al. (1996). Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre. EurJ Cancer Prev 5: 49-55.
56. Marple JT, MacDougall M, Chonko AM (1994). Renal cancer complicating acquired cystic kidney disease. J Am Soc Nephrol 4: 1951-6.
57. Mashberg A, Borsa P (1984). Screening for oral and orophararyngeal squamous carcinoma. G4 Cancer J Clin 34: 262-8.
58. McArdle JE, Lewin KJ, Randall G, Weinstein W (1992). Distribution of dysplasias and early invasive carcinoma in Barrett's esopahgus. Human Pathol 23: 479-82.
59. McNaughton Collins M, Fletcher RH (1997). Research questions concerning prostate cancer screening. Cancer Causes Control 8: 668-71.
60. McNaughton Collins M, Barry MJ (1996). Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate. JAMA 276: 1976-9.
61. Miller AB (1995). Screening for gastrointestinal cancer. Curr Opin Oncol 7: 373-6.
62. Mima S, Sekiya C, Kanagawa H et al. (1994). Mass screening for hepatocellular carcinoma: experience in Hokkaido, Japan. J Gastroenterol Hepatol 9: 361-5.
63. Morimoto T, Sasa M, Yamaguchi T et al. (1994). High detection rate of breast cancer by mass screening using mammography in Japan. Jpn J Cancer Res 85: 1193-5.
64. Morris J, McNoe B (1997). Screening for prostate cancer: what do general practitioners think? NZ Med J 110: 178-82.
65. Nakama H, Kamijo N, Abdul Fattah AS, Zhang B (1996). Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study. J Med Screen 3: 63-5.
66. National Institutes of Health Consensus Development Panel (1997). National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women aged 40-49, January 21-23, 1997.J Natl Cancer Inst 89: 1015-26.
67. Okamoto H, Ogawara T, Arihara F et al. (1996). Usefulness of ultrasonography combined with conventional physical examination in mass screening for breast cancer: a retrospective study of Yamanashi Health Care Center results from 1989 to 1994. Jpn J Cancer Res 87: 317-23.
68. Otten JD, van Dijck JA, Peer PG et al. (1996). Long term breast cancer screening in Nijmegen. The Netherlands: the nine rounds from 1975-92. J Epidemiol Comm Hlth 50: 353-8.
69. Parsonnet J, Axon ATR (1996). Principles of screening and surveillance. Am J Gastroenterol 91: 847-9.
70. Pisani P, Parkin DM, Munoz N, Ferlay J (1997). Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6: 387-400.
71. Provenzale D, Kemp JA, Arora S, Wong JB (1994). A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 89: 670-80.
72. Qin DX, Li JY, Sun LQ, Gu M et al. (1991). Sputum occult blood screening for lung cancer. Stage II screening of 14.431 subjects. Cancer 67: 1960-3.
73. Qin DX, Wang GQ, Zhang XH et al. (1996). New concept for cancer screening. Eur J Cancer Prev 5: 121-4.
74. Qin DX, Wang GQ, Zuo JH et al. (1993). Screening of esophageal and gastric cancer by occult blood bead detector. Cancer 71: 216-18.
75. Reissigl A, Pointner J, Horninger W et al. (1997). PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donors. Prostate 30: 20-5.
76. Reuss J (1994). Der Nierentumor als sonographischer Zufalls-befund. Ultraschall Med 15: 163-7.
77. Riddell RH (1996). Early detection of neoplasia of the esophagus and gastroesophageal junction. Am J Gastroenterol 91: 853-63.
78. Russell WJ, Higashi Y, Fukuya T et al. (1994). Ultrasonographic abdominal screening of atomic bomb-exposed subjects. Acta Radiol 35: 155-8.
79. Sackett DL (1997). A science for the art of consensus. J Natl Cancer Inst 89: 1003-5.
80. Saito H, Soma Y, Koeda J et al. (1995). Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemaglutination test. A case-control study. Int J Cancer 61: 465-9.
81. Saito Y, Takahashi S, Usuda K et al. (1996). Detection of early cancer by lung cancer screening. Jpn J Clin Med 54: 1410-14 (in Japanese).
82. Salkeld G, Young G, Irwig L et al. (1996). Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia. Aust NZ J Publ Hlth 20: 138-43.
83. Sarasin FP, Giostra E, Hadengue A (1996). Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Puch class A cirrhosis. Am J Med 101: 422-34.
84. Sasieni PD, Cuzick J, Lynch-Farmery E (1996). Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 73: 1001-5.
85. Satoh H, Ishikawa H, Yamashita YT et al. (1997). Outcome of patients with lung cancer detected by mass screening versus presentation with symptoms. Anticancer Res 17: 2293-6.
86. Shamsuddin AM (1996). A simple mucus test for cancer screening. Anticancer Res 16: 2193-9.
87. Shida H, Ban K, Matsumoto M et al. (1996). Asymptomatic colorectal cancer detected by screening. Dis Colon Rect 39: 1130-5.
88. Smith S, Warnakulasuriya S, Johnson NW (1995). Baseline knowledge of oral cancer and the effect of training on diagnostic accuracy for oral mucosal lesions amongst General Dental Practitioners (GDPs). J Dent Res 74: 843.
89. Soliman AS, Raouf AA, Chamberlain RM (1997). Knowledge of attitudes toward, and barrier to. cancer control and screening among primary care physicians in Egypt. J Cancer Ed 12: 100-7.
90. Stenkvist B, Söderström J (1996). Reasons for cervical cancer despite extensive screening. J Med Screen 3: 204-7.
91. Strauss GM, Gleason RE, Sugarbaker DJ (1997). Screening for lung cancer. Another look: a different view. Chest 111: 754-68.
92. Strom BL, Maislin G, West SL et al. (1990). Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer? Int J Cancer 45: 821-4.
93. Tanaka S, Kitamra T, Yamamoto K et al. (1996). Evaluation of routine sonography for early detection of pancreatic cancer. Jpn J Clin Oncol 26: 422-7.
94. Tang CS, Tang CM, Lau YY, Kung IT (1995). Sensitivity of sputum cytology after homogenization with dithiothreitol in lung cancer detection. Two years of experience. Acta Cytologica 39: 1137-40.
95. Thon WF, Kliem V, Truss MC et al. (1995). Denovo urothelial carcinoma of the upper and lower urinary tract in kidney-transplant patients with end-stage analgesic nephropathy. World J Urol 13: 254-61.
96. Toh Y, Baba K, Ikebe M et al. (1993). Endoscopic ultrasonography in the diagnosis of an early esophageal carcinoma. Hepato-Gastroenterol 40: 212-16.
97. Torgerson DJ, Gosden T (1997). The national breast screening service: is it economically efficient? QJM 90: 423-5.
98. Tsubono Y, Kobayashi M, Tsugane S (1997). Food consumption and gastric cancer mortality in five regions of Japan. Nutr Cancer 27: 60-4.
99. Tsugane S, Kabuto M, Imai H et al. (1993). Helicobacter pylori, dietary factors and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 4: 297-305.
100. Van Nagell JR Jr, Gallion HH, Pavlik EJ, DePriest PD (1995). Ovarian cancer screening. Cancer 76: 2086-91.
101. Verne JECW, Aubrey R, Love SB, Talbot IC, Northover JMA (1998). Population based randomised study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 317: 182-5.
102. Vernon SW (1997). Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89: 1406-22.
103. Warmerdam PG, de Koning HJ, Boer R et al. (1997). Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany. J Epidemiol Comm HIth 51: 180-6.
104. Warnakulasuriya KAAS, Johnson NW (1996). Strength and weaknesses of screening programmes for oral malignancies and potentially malignant lesions. EurJ Cancer Prev 5: 93-8.
105. Watanabe S, Matsuda K, Arima K et al. (1996). Detection of subclinical disorders of the hypopharynx and larynx by gastrointestinal endoscopy. Endoscopy 28: 295-8.
106. Whitmore SE, Anhalt GJ, Provost TT et al. (1997). Serum CA-125 screening for ovarian cancer in patients with dermato-myositis. Gynecol Oncol 65: 241-4.
107. Wilson JL, Stein DS (1997). The impact of public education videotapes on knowledge about cancer. J Cancer Ed 12: 51-4.
108. Yamauchi S, Koga A, Matsumoto S et al. (1987). Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol 82: 20-4.
109. Yang B, Zhang B, Xu Y et al. (1997). Prospective study of early detection for primary liver cancer. J Cancer Res Clin Oncol 123: 357-60.
110. Yokoyama A, Ohmori T, Makuuchi H et al. (1995). Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining. Cancer 76: 928-34.
111. Yoshida S, Saito D (1996). Gastric premalignancy and cancer screening in high-risk patients. Am J Gastroenterol 91: 839-43.
112. Yoshihara M, Sumii K, Haruma K et al. (1997). The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography. Hiroshima J Med Sci 46: 81-6.
113. Zatonski WA, Lowenfels AB, Boyle P et al. (1997). Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst 89: 1132-8.